Netherlands· NL-c940a29b611a
Paclitaxel Accord 6 mg/ml concentraat voor oplossing voor infusie
A paclitaxel product containing paclitaxel, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Paclitaxel is registered in 16 of 19 countries.
Countries holding a registration under ATC L01CD01 (paclitaxel), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Paclitaxel · ATC L01CD01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of paclitaxel costs, country by country.
Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.61 in Czechia to $19.82 in Switzerland — a ×32 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Paclitaxel · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$19.82
- CZ Czechia$0.61
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- PACLITAXEL
- Manufacturer
- Accord Healthcare B.V.
- Country
- Netherlands (NL)
- ATC code
- L01CD01
- ATC class
- Paclitaxel
- Defined daily dose
- 15 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id102965
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
651 interactions on record for paclitaxel.
Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Paclitaxel · interactions on record
651 records
- 41 severe
- 302 moderate
- 17 minor
- 291 info
Most severe, free to view
- SaquinavirJ05AE01severe
- IndinavirJ05AE02severe
- RitonavirJ05AE03severe
- NelfinavirJ05AE04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Paclitaxel in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FrancePACLITAXEL AHCL 6 mg/ml, solution à diluer pour perfusionACCORD HEALTHCARE FRANCE
- United KingdomAbraxane 100mg powder for dispersion for infusion vialsBristol-Myers Squibb Pharmaceuticals Ltd
- United StatesABRAXANEAbraxis BioScience, LLC
- BelgiumApacross 5 mg/mlSeacross Pharma (Europe)
- CzechiaABRAXANEBristol-Myers Squibb Pharma EEIG, Dublin
- FinlandAbraxaneOrifarm Oy
- GermanyApacrossSeacross Pharma (Europe) Ltd
- SwitzerlandAbraxane
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Apacross, Bugvi
- Belgium · Apacross, Bugvi
- Bulgaria · Алсикроса, Паклитаксел Акорд
- Cyprus · Paclitaxel Accord, Paclitaxel Hospira
- Czechia · Alsicrosa, Paclitaxel Ebewe
- Germany · Apacross, Axitaxel
- Denmark · Apacross, Bugvi
- Estonia · Paclitaxel Accord, Paclitaxel Ebewe
- Spain · Apacross, Bugvi
- Finland · Apacross, Pacligen
- France · Bugvi, Paclitaxel Ahcl
- United Kingdom (Northern Ireland) · Apacross, Paclitaxel
- Greece · Biotaxel, Paclitaxel Hospira
- Croatia · Abutrax, Alsicrosa
- Hungary · Bugvi, Paclitaxel Accord
- Ireland · Apacross, Paclitaxel
- Iceland · Abraxane, Apexelsin
- Italy · Abutrax, Apacross
- Liechtenstein · Abraxane, Apexelsin
- Lithuania · Paclitaxel Accord, Paclitaxel Ebewe
- Luxembourg · Bugvi, Paclitaxel Accord Healthcare
- Latvia · Paclitaxel Accord, Paclitaxel Kabi
- Malta · Paclitaxel Accord Healthcare, Paclitaxel Hospira
- Norway · Abraxane, Apacross
- Poland · Paclitaxel Ebewe, Paclitaxel Kabi
- Portugal · Apacross, Paclitaxel Accord
- Romania · Bugvi, Paclitaxel Accord
- Sweden · Apacross, Bugvi
- Slovenia · Alsicrosa, Paclitaxin
- Slovakia · Paclitaxel Accord, Paclitaxel Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d31bca9e-a027-497e-9458-5fcb880d7b7f GET /v1/drugs/d31bca9e-a027-497e-9458-5fcb880d7b7f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h102965_smpc.pdf",
"strength": null,
"atc_label": "Paclitaxel",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg102965",
"excipients": [
"ETHANOL",
"MACROGOLGLYCEROLRICINOLEAAT",
"STIKSTOF (HEAD SPACE) (E 941)"
],
"substances": [
"PACLITAXEL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h102965.pdf",
"authorised_at": "2010/08/31",
"procedure_number": "NL/H/1444/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "102965",
"additional_monitoring": "N"
}See everything about paclitaxel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.